Utilization and Regional Disparities of Radiotherapy in Cancer Treatment in Japan: a Longitudinal Study Using NDB Open Data

Overview

Journal J Radiat Res

Publisher Oxford University Press

Specialties Environmental Health
Oncology
Radiology

Date 2024 Dec 26

PMID 39724924

Authors

Kazuya Takeda

Rei Umezawa

Takaya Yamamoto

Noriyoshi Takahashi

Hiroshi Onishi

Keiichi Jingu

Affiliations

Soon will be listed here.

Abstract

The National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) is a database that stores anonymized information on medical receipts and health checkups in Japan. The NDB Open Data is a publicly accessible summary table of the NDB database. To reveal annual trends and regional disparities in radiotherapy utilization in Japan, we analyzed the NDB Open Data tables for a 9-year period from 2014 to 2022. We extracted medical cost codes for radiotherapy management fees and specific types of radiotherapy, such as stereotactic irradiation (STI) and intensity-modulated radiotherapy (IMRT), to analyze nationwide changes over time. To investigate regional disparities, we counted the three subitems representing 3-dimensional conformal radiotherapy (3D-CRT), IMRT, and STI for each prefecture per year. The utilization of advanced radiotherapy techniques, such as IMRT (199% increase), increased, while the use of simpler forms of irradiation, such as 1 or 2-opposite fields irradiation (40% decrease), decreased in the period from 2014 to 2022. Regarding regional disparities, the coefficients of variation in 47 prefectures for 3D-CRT remained relatively stable at 0.17 in 2014 and 0.18 in 2022, while the coefficients of variation for IMRT and STI decreased from 0.64 and 0.39 in 2014 to 0.31 and 0.36 in 2022, respectively. The popularization of IMRT was correlated with the number of certified radiation oncologists in the prefecture. In conclusion, although the utilization of high-precision radiotherapy in Japan has been increasing and regional differences have been diminishing, there are still persistent disparities.

References

Howell D, James J, Hartsell W, Suntharalingam M, Machtay M, Suh J . Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14. Cancer. 2012; 119(4):888-96. PMC: 5746185. DOI: 10.1002/cncr.27616. View

Chan J, Polo A, Zubizarreta E, Bourque J, Hanna T, Gaudet M . Access to radiotherapy and its association with cancer outcomes in a high-income country: Addressing the inequity in Canada. Radiother Oncol. 2019; 141:48-55. DOI: 10.1016/j.radonc.2019.09.009. View

Bryant A, Huynh-Le M, Simpson D, Mell L, Gupta S, Murphy J . Intensity Modulated Radiation Therapy Versus Conventional Radiation for Anal Cancer in the Veterans Affairs System. Int J Radiat Oncol Biol Phys. 2018; 102(1):109-115. DOI: 10.1016/j.ijrobp.2018.05.044. View

Beckett M, Goethals L, Kraus R, Denysenko K, Barone Mussalem Gentiles M, Pynda Y . Proximity to Radiotherapy Center, Population, Average Income, and Health Insurance Status as Predictors of Cancer Mortality at the County Level in the United States. JCO Glob Oncol. 2023; 9:e2300130. PMC: 10581634. DOI: 10.1200/GO.23.00130. View

Aoyama T, Koide Y, Shimizu H, Kitagawa T, Iwata T, Hashimoto S . Trends and distribution of external radiation therapy facilities in Japan based on Survey of Medical Institutions from the Ministry of Health, Labour and Welfare. J Radiat Res. 2024; 65(3):328-336. PMC: 11115472. DOI: 10.1093/jrr/rrae014. View

Yamamoto M, Curley J, Hirata H . Trends in Open vs. Endoscopic Carpal Tunnel Release: A Comprehensive Survey in Japan. J Clin Med. 2022; 11(17). PMC: 9456605. DOI: 10.3390/jcm11174966. View

Hattori Y, Hamada S, Ishizaki T, Sakata N, Iwagami M, Tamiya N . National trends in gastrostomy in older adults between 2014 and 2019 in Japan. Geriatr Gerontol Int. 2022; 22(8):648-652. DOI: 10.1111/ggi.14433. View

Ball D, Tao Mai G, Vinod S, Babington S, Ruben J, Kron T . Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. 2019; 20(4):494-503. DOI: 10.1016/S1470-2045(18)30896-9. View

Katano A, Minamitani M, Yamashita H, Nakagawa K . National Survey of Radiotherapy Utilization Trends from 2015 to 2019, Based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan. JMA J. 2023; 6(3):342-345. PMC: 10407371. DOI: 10.31662/jmaj.2022-0142. View

10.

Michalski J, Yan Y, Watkins-Bruner D, Bosch W, Winter K, Galvin J . Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys. 2013; 87(5):932-8. PMC: 3840044. DOI: 10.1016/j.ijrobp.2013.07.041. View

11.

Gupta T, Kannan S, Ghosh-Laskar S, Agarwal J . Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma. PLoS One. 2018; 13(7):e0200137. PMC: 6034843. DOI: 10.1371/journal.pone.0200137. View

12.

Okui T, Park J . Analysis of regional differences in the amount of hypnotic and anxiolytic prescriptions in Japan using nationwide claims data. BMC Psychiatry. 2022; 22(1):44. PMC: 8772209. DOI: 10.1186/s12888-021-03657-6. View

13.

Wu J, Wong R, Johnston M, Bezjak A, Whelan T . Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003; 55(3):594-605. DOI: 10.1016/s0360-3016(02)04147-0. View

14.

Lee J, Kim W, Yoon W, Rim C . Implications of Radiotherapy Utilization in Korea from 2010 to 2019. J Korean Med Sci. 2021; 36(18):e117. PMC: 8111041. DOI: 10.3346/jkms.2021.36.e117. View

15.

Numasaki H, Nakada Y, Okuda Y, Ohba H, Teshima T, Ogawa K . Japanese structure survey of radiation oncology in 2015. J Radiat Res. 2022; 63(2):230-246. PMC: 8944304. DOI: 10.1093/jrr/rrab129. View

16.

Kubota H, Nakamura N, Shikama N, Tonari A, Wada H, Harada H . Practice patterns for postoperative radiation therapy in patients with metastases to the long bones: a survey of the Japanese Radiation Oncology Study Group. J Radiat Res. 2021; 62(2):356-363. PMC: 7948830. DOI: 10.1093/jrr/rraa133. View

17.

Cahlon O, Zelefsky M, Shippy A, Chan H, Fuks Z, Yamada Y . Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys. 2008; 71(2):330-7. DOI: 10.1016/j.ijrobp.2007.10.004. View